Advertisement

Diarrhea pp 141-157 | Cite as

Radiation Enterocolitis

  • Einar G. Lurix
  • Jorge A. Zapatier
  • Andrew Ukleja
Chapter
Part of the Clinical Gastroenterology book series (CG)

Summary

This chapter is focused on review of the diagnostic tests and management of radiation enterocolitis. Radiation enterocolitis can occur after radiation therapy for urological, gynecological, and gastrointestinal cancer. Diarrhea, which is often a dominant symptom, can develop from a few weeks to many years after radiation treatment depending on the severity and the extent of the injury. Radiation enterocolitis can result in severe refractory diarrhea associated with progressive weight loss, abdominal pain, and malnutrition. Diagnosis of radiation enterocolitis can be a challenge. Properly selected radiographic and endoscopic studies allow for detection of subtle changes in the bowel from radiation. A history of prior radiation is a key to make the diagnosis, since other conditions can mimic radiographic, endoscopic, and histologic findings of radiation injury. Management of radiation enterocolitis is directed toward symptoms control. Surgery may be required if conservative measures fail.

Key Words

Diarrhea Radiation enteritis Malabsorption 

References

  1. 1.
    Fajardo LP. Pathology of radiation injury. New York: Masson Publishers, 1982, pp. 47–76.Google Scholar
  2. 2.
    Herlinger H, Maglinte D, Birnbaum B. Clinical imaging of the small intestine. New York: Springer, 2001.Google Scholar
  3. 3.
    MacNaughton W. Review article: new insights into the pathogenesis of radiation induced intestinal dysfunction. Aliment Pharmacol Ther 2000;14:523–528.PubMedCrossRefGoogle Scholar
  4. 4.
    Vasudeva R. Intestinal radiation injury. Emedicine 2010. Retrieved July 23, 2010 from http://emedicine.medscape.com/article/180084-print.
  5. 5.
    Miller AR, Martenson JA, Nelson H, et al. The incidence and clinical consequences of treatment-related bowel injury. Int J Radiat Oncol Biol Phys 1999;43:817–825.PubMedCrossRefGoogle Scholar
  6. 6.
    Turina M, Mulhall AM, Mahid SS, et al. Frequency and surgical management of chronic complications related to pelvic radiation. Arch Surg 2008;143:46–52.PubMedCrossRefGoogle Scholar
  7. 7.
    Kopelman Y, Groissman G, Fireman Z. Radiation enteritis diagnosed by capsule endoscopy. Gastrointest Endosc 2007;66:599.PubMedCrossRefGoogle Scholar
  8. 8.
    Kinsella TJ, Bloomer WD. Tolerance of the intestine to radiation therapy. Surg Gynecol Obstet 1980;151:273–284.PubMedGoogle Scholar
  9. 9.
    Yoshimura K, Hirata I, Maemura K, et al. Radiation enteritis: a rare complication of the transverse colon in uterine cancer. Intern Med. 2000;39:1060–1063.PubMedCrossRefGoogle Scholar
  10. 10.
    Macari M, Balthazar E. CT of bowel wall thickening: significance and pitfalls of interpretation. Am Roentgen Ray Soc 2001;176:1105–1115.Google Scholar
  11. 11.
    Lawrance IC, et al. Small bowel MRI enteroclysis or follow through: which is optimal? World J Gastroenterol 2009;15:5300–5306.PubMedCrossRefGoogle Scholar
  12. 12.
    Yano T, Yamamoto H. Current state of double balloon endoscopy: the latest approach to small intestinal diseases. J Gastroenterol Hepatol. 2009;24: 185–192.PubMedCrossRefGoogle Scholar
  13. 13.
    Pasha S, Harrison M, Leighton J. Obscure GI bleeding secondary to radiation enteritis diagnosed and successfully treated with retrograde double-balloon enteroscopy. Gastrointest Endosc 2007;65:552–554.PubMedCrossRefGoogle Scholar
  14. 14.
    Weiss E, Hirnle P, Arnold-Bofinger H, et al. Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma stage I and II. Radiother Oncol 1999;53:37–44.PubMedCrossRefGoogle Scholar
  15. 15.
    Chen AB, D’Amico AV, Neville BA, et al. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol 2006;24:5298–5304.PubMedCrossRefGoogle Scholar
  16. 16.
    Norkus D, Miller A, Kurtinaitis J, et al. A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma: a report on acute toxicity. Strahlenther Onkol 2009;185:715–721.PubMedCrossRefGoogle Scholar
  17. 17.
    Alongi F, Fiorino C, Cozzarini C, et al. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 2009;93: 207–212.PubMedCrossRefGoogle Scholar
  18. 18.
    Athanassiou H, Antonadou D, Coliarakis N, et al. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J radat Oncol Biol Phys 2003;56:1154–1160.CrossRefGoogle Scholar
  19. 19.
    Blanarova C, Galovicova A, Petrasova D. Use of probiotics for prevention of radiation-induced diarrhea. Bratisl Lek Listy 2009;110:98–104.PubMedGoogle Scholar
  20. 20.
    Adler U. On control of radioenteritis by the administration of living lactobacilli in gynecological carcinoma patients. Ther Umsch 1962;19:283–285.PubMedGoogle Scholar
  21. 21.
    Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007;13:912–915.PubMedGoogle Scholar
  22. 22.
    Burch RM, McMillan BA. Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full-thickness skin wounds. Agents Actions 1991;34:229–231.PubMedCrossRefGoogle Scholar
  23. 23.
    Matsuu-Matsuyama M, Shichijo K, Okaichi K, et al. Sucralfate protects intestinal epithelial cells from radiation-induced apoptosis in rats. J Radiat Res 2006:47:1–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Martenson JA, Bollinger JW, Sloan JA, et al. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: a North Central Cancer Treatment Group phase III double-blind placebo-controlled trial. J Clin Oncol 2000;18:1239–1245.PubMedGoogle Scholar
  25. 25.
    Greenfield SM, Punchard NA, Teare JP, et al. Review article: the mode of action of the aminosalicylates in inflammatory bowel disease. Aliment Pharmacol Ther 1993;7:369–383.PubMedCrossRefGoogle Scholar
  26. 26.
    Hawkey CJ, Boughton-Smith NK, Whittle BJ. Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci 1985;30:1161–1165.PubMedCrossRefGoogle Scholar
  27. 27.
    Kilic D, Egehan I, Ozenirler S, et al. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol 2000;57: 125–129.PubMedCrossRefGoogle Scholar
  28. 28.
    Jahraus CD, Bettenhausen D, Malik U, et al. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients. Int J Radiat Oncol Biol Phys 2005;63:1483–1487.PubMedCrossRefGoogle Scholar
  29. 29.
    Resbeut M, Marteau P, Cowen D, et al. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol 1997;44:59–63.PubMedCrossRefGoogle Scholar
  30. 30.
    Kountouras J, Zavos C. Recent advances in the management of radiation colitis. World J Gastroenterol 2008;14:7289–7301.PubMedCrossRefGoogle Scholar
  31. 31.
    Sekhon S. Chronic radiation enteritis: women’s food tolerances after radiation treatment for gynecologic cancer. J Am Diet Assoc 2000;100:941–943.PubMedCrossRefGoogle Scholar
  32. 32.
    Chapaux J, Chapaux P, Royer E. Loperamide in patients with radiotherapy-induced diarrhoea. Arzneimittelforschung 1978;28:864–866.PubMedGoogle Scholar
  33. 33.
    Yeoh EK, Horowitz M, Russo A, et al. Gastrointestinal function in chronic radiation enteritis—effects of loperamide-N-oxide. Gut 1993;34:476–482.PubMedCrossRefGoogle Scholar
  34. 34.
    Fuccio L, Guido A, Eusebi LH, Laterza L, et al. Effects of probiotics for the prevention and treatment of radiation-induced diarrhea. J Clin Gastroenterol 2009;43:506–513.PubMedCrossRefGoogle Scholar
  35. 35.
    Goldstein, F, Khoury, J, Thornton, JJ. Treatment of chronic radiation enteritis and colitis with salicylazosulfapyridine and systemic corticosteroids. A pilot study. Am J Gastroenterol 1976; 65:201.PubMedGoogle Scholar
  36. 36.
    Hille A, Christiansen H, Pradier O, et al. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 2005;181:606–614.PubMedCrossRefGoogle Scholar
  37. 37.
    Zimmerer T, Böcker U, Wenz F, et al. Medical prevention and treatment of acute and chronic radiation induced enteritis—is there any proven therapy? a short review. Z Gastroenterol 2008;46:441–448.PubMedCrossRefGoogle Scholar
  38. 38.
    Feldmeier JJ, Davolt DA, Court WS, et al. Histologic morphometry confirms a prophylactic effect for hyperbaric oxygen in the prevention of delayed radiation enteropathy. Undersea Hyperb Med 1998;25:93–97.PubMedGoogle Scholar
  39. 39.
    Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med 2002;29:4–30.PubMedGoogle Scholar
  40. 40.
    Baillie-Johnson HR. Octreotide in the management of treatment-related diarrhoea. Anticancer Drugs 1996;7:11–15.PubMedCrossRefGoogle Scholar
  41. 41.
    Topkan E, Karaoglu A. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. Oncology 2006;71:354–360.PubMedCrossRefGoogle Scholar
  42. 42.
    Arlow FL, Dekovich AA, Priest RJ, et al. Bile acids in radiation-induced diarrhea. South Med J 1987;80:1259–1261.PubMedCrossRefGoogle Scholar
  43. 43.
    Chary S, Thomson DH. A clinical trial evaluating cholestyramine to prevent diarrhea in patients maintained on low-fat diets during pelvic radiation therapy. Int J Radiat Oncol Biol Phys 1984;10:1885–1890.PubMedCrossRefGoogle Scholar
  44. 44.
    Ippoliti C. Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients. Am J Health Syst Pharm 1998;55:1573–1580.PubMedGoogle Scholar
  45. 45.
    Vidal A, et al. Chronic radiation enteritis after ovarian cancer: from home parenteral nutrition to oral diet. Clin Nutr 2006;25:701–704.PubMedCrossRefGoogle Scholar
  46. 46.
    Scolapio JS, Ukleja A, Burnes JU, et al. Outcome of patients with radiation enteritis treated with home parenteral nutrition. Am J Gastroenterol 2002;97:662–666.PubMedCrossRefGoogle Scholar
  47. 47.
    Copeland EM, Souchon EA, MacFadyen BV Jr, et al. Intravenous hyperalimentation as an adjunct to radiation therapy. Cancer 1977;39:609–616.PubMedCrossRefGoogle Scholar
  48. 48.
    Mann W. Surgical management of radiation enteropathy. Surg Clin N Am 1991;71:5.Google Scholar
  49. 49.
    Alexander-Williams J. The management of intestinal fistulae. Helv Chir Acta 1994;60:1025–1029.PubMedGoogle Scholar
  50. 50.
    Turina M, Mulhall AM, Mahid SS, et al. Frequency and surgical management of chronic complications related to pelvic radiation. Arch Surg 2008;143:46–52.PubMedCrossRefGoogle Scholar
  51. 51.
    Waddell BE, Rodríguez-Bigas MA, Lee RJ, et al. Prevention of chronic radiation enteritis. J Am Coll Surg 1999;189:611–624.PubMedCrossRefGoogle Scholar
  52. 52.
    Regimbeau JM, et al. Operative and long term results after surgery for chronic radiation enteritis. Am J Surg 2001;182:237–242.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Einar G. Lurix
    • 1
  • Jorge A. Zapatier
    • 2
  • Andrew Ukleja
    • 3
  1. 1.Department of GastroenterologyCleveland Clinic FloridaWestonUSA
  2. 2.Department of Internal MedicineCleveland Clinic FloridaWestonUSA
  3. 3.Department of GastroenterologyCleveland Clinic FloridaWestonUSA

Personalised recommendations